Adekunle Alabi, PhD

Assistant Professor, Pathology


FacultyPhoto
Graduate Schools
  • PhD, University of Alberta (2020)
  • MSc, University of Lincoln (2013)
Fellowships
  • University of California (San Diego) Program, Chemical Pathology (2024)
Department
Pathology

Professional Titles

  • Medical Director-Toxicology and Mass Spectrometry

Recognitions

  • American Heart Postdoctoral Fellowship, American Heart Association (2022)
  • Medstar Award of Academic Excellence, Faculty of Medicine & Dentistry University of Alberta (2021)
  • Educational Grant, Mass Spectrometry & Advances in Clinical Lab (MSACL) (2024)
  • Motyl Graduate Studentships in Cardiac Sciences, Faculty of Medicine & Dentistry University of Alberta (2019)

Research Interests

My research interests encompass clinical chemistry, toxicology, and therapeutic drug monitoring, with a particular focus on the analysis and interpretation of chemical processes within the body. I am also deeply interested in lipid and cholesterol metabolism, as well as metabolic diseases. My work aims to advance our understanding of these areas to improve patient care and outcomes through precise monitoring and innovative therapeutic approaches

Publications

  • Alabi A, Ge M, Momper JD, Tsunoda SM, Kelner MJ, Fitzgerald RL, Suhandynata RT. Measurement of Whole Blood Tacrolimus Concentrations by LC-MS/MS and Immunoassay Methods: Influence of Immediate-Release vs Extended-Release Tacrolimus Formulations. J Appl Lab Med. 2025 Jan 31. PubMed PMID: 39887045.
  • Ge M, Alabi A, Kelner MJ, Fitzgerald RL, Suhandynata RT. Evaluation of a Benzodiazepine Immunoassay for Urine Drug Testing in Clinical Specimens. J Appl Lab Med. 2024 Nov 4;9(6):964-976. PubMed PMID: 39163145
  • Xia XD, Gill G, Lin H, Roth DM, Gu HM, Wang XJ, Su FY, Alabi A, Alexiou M, Zhang Z, Wang GQ, Graf D, Zhang DW. Global, but not chondrocyte-specific, MT1-MMP deficiency in adult mice causes inflammatory arthritis. Matrix Biol. 2023 Sep;122:10-17. PubMed PMID: 37598898
  • Madhavan A, Kok BP, Rius B, Grandjean JMD, Alabi A, Albert V, Sukiasyan A, Powers ET, Galmozzi A, Saez E, Wiseman RL. Pharmacologic IRE1/XBP1s activation promotes systemic adaptive remodeling in obesity. Nat Commun. 2022 Feb 1;13(1):608. PubMed PMID: 35105890
  • Wang M, Alabi A, Gu HM, Gill G, Zhang Z, Jarad S, Xia XD, Shen Y, Wang GQ, Zhang DW. Identification of amino acid residues in the MT-loop of MT1-MMP critical for its ability to cleave low-density lipoprotein receptor. Front Cardiovasc Med. 2022;9:917238. PubMed PMID: 36093157
  • Alabi A, Xia XD, Gu HM, Wang F, Deng SJ, Yang N, Adijiang A, Douglas DN, Kneteman NM, Xue Y, Chen L, Qin S, Wang G, Zhang DW. Membrane type 1 matrix metalloproteinase promotes LDL receptor shedding and accelerates the development of atherosclerosis. Nat Commun. 2021 Mar 25;12(1):1889. PubMed PMID: 33767172
  • Wang B, Shen Y, Zhai L, Xia X, Gu HM, Wang M, Zhao Y, Chang X, Alabi A, Xing S, Deng S, Liu B, Wang G, Qin S, Zhang DW. Atherosclerosis-associated hepatic secretion of VLDL but not PCSK9 is dependent on cargo receptor protein Surf4. J Lipid Res. 2021;62:100091. PubMed PMID: 34118252
  • Xia XD, Alabi A, Wang M, Gu HM, Yang RZ, Wang GQ, Zhang DW. Membrane-type I matrix metalloproteinase (MT1-MMP), lipid metabolism, and therapeutic implications. J Mol Cell Biol. 2021 Oct 21;13(7):513-526. PubMed PMID: 34297054
  • Shen Y, Wang B, Deng S, Zhai L, Gu HM, Alabi A, Xia X, Zhao Y, Chang X, Qin S, Zhang DW. Surf4 regulates expression of proprotein convertase subtilisin/kexin type 9 (PCSK9) but is not required for PCSK9 secretion in cultured human hepatocytes. Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Feb;1865(2):158555. PubMed PMID: 31676436
  • Deng SJ, Alabi A, Gu HM, Adijiang A, Qin S, Zhang DW. Identification of amino acid residues in the ligand binding repeats of LDL receptor important for PCSK9 binding. J Lipid Res. 2019 Mar;60(3):516-527. PubMed PMID: 30617148
  • Gu HM, Wang F, Alabi A, Deng S, Qin S, Zhang DW. Identification of an Amino Acid Residue Critical for Plasma Membrane Localization of ATP-Binding Cassette Transporter G1--Brief Report. Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):253-5. PubMed PMID: 26695502
  • Alabi A, Caballero-Casero N, Rubio S. Quick and simple sample treatment for multiresidue analysis of bisphenols, bisphenol diglycidyl ethers and their derivatives in canned food prior to liquid chromatography and fluorescence detection. J Chromatogr A. 2014 Apr 4;1336:23-33. PubMed PMID: 24594089

Practice Locations

Leprino Building
12401 E. 17th Ave
Aurora, CO 80045

Hospital Affiliation
  • University of Colorado Hospital

Specialty Information

Specialties
  • National Registry of Certified Chemist, Board Certification (2024)
  • Diplomate of American Board of Clinical Chemistry, Board Certification (2024)
  • American Society for Clinical Pathology, Board Certification (2025)
Clinical Interests
My clinical interests include clinical chemistry, toxicology, and therapeutic drug monitoring. I am dedicated to the analysis and interpretation of chemical processes within the body, the study of toxins and their effects, and the monitoring of drug levels to ensure effective and safe patient care.

Care Philosophy
My care philosophy centers on the precise analysis and interpretation of chemical processes within the body, the study of toxins and their effects, and the monitoring of drug levels to ensure effective and safe patient care. I am committed to providing comprehensive care through clinical chemistry, toxicology, and therapeutic drug monitoring, ensuring that each patient receives the highest standard of care tailored to their unique needs